(The Center Square ) – After submitting comments to the Federal Trade Commission’s public inquiry on how the child transgender industry has harmed and deceived consumers, the medical group Do No Harm expects action to protect the nation’s children .

Do No Harm medical director Dr. Kurt Miceli told The Center Square: “We anticipate the FTC will take meaningful action considering the public comments it has received – protecting vulnerable children from unsafe and unproven sex change interventions, while also seeking justice for those who have already been harmed.”

Recommended Stories

Trump announces deal with AstraZeneca to lower drug costs

WATCH LIVE: Trump makes announcement regarding drug prices

RFK Jr. criticizes media coverage of comments on circumcision and autism

“The FTC

See Full Page